The main market opportunities in the RSV prophylaxis field lie in the development of new monoclonal antibodies and vaccines, with substantial growth expected due to late-stage pipeline products. This ...

Antar stressed that “what remains of the coronavirus is merely scattered, non-impactful droplets, and no variant of the ...

Based on reports from doctors participating in the surveillance service, it is estimated that 185,900 people visited a doctor ...

On Thursday 27 November 2025, the Health Directorate of Luxembourg's Ministry of Health and Social Security published its ...

A new study published in the journal of Arthritis & Rheumatology revealed that patients with rheumatoid arthritis-associated ...

BRITS are being urged to look out for symptoms of RSV after an increase in cases of the highly contagious disease. The virus ...

UK Health Security Agency data show flu infections, hospitalisations and intensive care admissions all increased again last week ...

People aged 75 to 79, as well as people who turned 80 after 1 September 2024, are eligible for a vaccine to protect against respiratory syncytial virus (RSV). RSV affects the airways and lungs and can ...

Winter leaves working parents juggling cough drops, surprise school pick-ups and sick days that refuse to slow down. Each spike in classroom absences sends families ... Read more The post A tough ...

You recently posted a couple of articles about the respiratory syncytial virus (RSV) vaccine and the benefits versus the risks. I know the risks are based on ...